IL18 and macrophage activation syndrome: Further, since caspase-1 inhibition exhibited the same phenotype as NLRP3 inhibition, this suggests that only the NLRP3 inflammasome is responsible for enhanced levels of plasma IL-18 in CpG-induced MAS.